{"id":"NCT03836807","sponsor":"Dompé Farmaceutici S.p.A","briefTitle":"A Study to Assess Efficacy and Tolerability of Ketoprofen 40 mg Granules vs Placebo","officialTitle":"A Multicenter, Double Blind, Randomised, Parallel Study to Assess Efficacy and Tolerability After Single Administration of Ketoprofen Lysine Salt 40 mg Granules vs Placebo in Subjects With Acute Pain Syndrome After Removal of Molar Teeth","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-04","primaryCompletion":"2018-07-04","completion":"2018-12-21","firstPosted":"2019-02-11","resultsPosted":"2024-04-15","lastUpdate":"2024-04-24"},"enrollment":70,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pain"],"interventions":[{"type":"DRUG","name":"OKITASK®","otherNames":["ketoprofen lysine salt (KLS)"]},{"type":"OTHER","name":"Placebo","otherNames":["Control"]}],"arms":[{"label":"OKITASK®","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Primary objective:\n\nTo assess the efficacy of OKITASK® 40 mg granules versus Placebo in patients with acute pain syndrome after removal of one molar tooth by comparing AUC0-6h of posttreatment pain profile measured by VAS.\n\nSecondary objectives:\n\nTo assess the following efficacy and safety parameters of OKITASK® 40 mg granules versus Placebo in patients with acute pain syndrome after removal of one molar tooth:\n\n* Time profile of pain and time profile of pain relief using VAS scales\n* Time to first perceptible pain relief (TFPR) and time to meaningful pain relief (TMPR)\n* Proportion of patients requiring rescue medication (analgesia) and time to rescue analgesia\n* Patient's overall assessment\n* Rate of adverse events (AE)","primaryOutcome":{"measure":"AUC0-6h of Pain Intensity Between Time 0 (Baseline Value of VAS) and 6 Hours Post-treatment in the ITT Population.","timeFrame":"time 0', 5', 10', 15', 30', 60' (1 hour), 90' (1.5 hours), 120' (2 hours), 180' (3 hours), 240' (4 hours), 300' (5 hours), and 360' (6 hours) post-treatment","effectByArm":[{"arm":"OKITASK","deltaMin":5031,"sd":3250},{"arm":"Placebo","deltaMin":7593,"sd":5402}],"pValues":[{"comp":"OG000 vs OG001","p":"0.020"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["Headache"]}}